Navigation Links
Westaim to deregister its common stock in the United States
Date:10/20/2008

CALGARY, Oct. 20 /PRNewswire-FirstCall/ - The Westaim Corporation announced today its intention to deregister and terminate its reporting obligations associated with its previous Nasdaq listing under Sections 12(g) and 15(d) of the U.S. Securities and Exchange Act of 1934, as amended.

The deregistration and termination in the United States will have no effect over the Company's common stock or over its shareholders. Westaim's shares will continue to trade on the TSX under the symbol WED. Additionally, the Company does not foresee any material financial effect over its assets, liabilities and results.

During 2007, the bid price of Westaim's common shares listed on Nasdaq was below US$1.00 for longer than 180 days in contravention of Nasdaq Marketplace Rule 4450(a)(5) and as a result the Company's shares were delisted from the Nasdaq and suspended from trading on October 18, 2007.

In connection with the deregistration and termination in the United States, Westaim will immediately file a Form 15F with the SEC. Upon the filing of Form 15F, the Company's reporting obligations under the Exchange Act will be suspended immediately. These reporting obligations will be finally terminated after a 90-day waiting period, provided that the SEC does not raise objections.

The Westaim Corporation's common shares are listed on The Toronto Stock Exchange under the trading symbol WED.

This news release contains forward-looking statements. These statements are based on current expectations that are subject to risks and uncertainties, and Westaim can give no assurance that these expectations are correct. Various factors could cause actual results to differ materially from those projected in such statements, including but not limited to statements regarding the Company's intention to deregister and terminate its reporting obligations associated with its previous Nasdaq listing, the anticipated filing of a Form 15F with the SEC, the date of any filing, the impact of any filing on the Company's reporting obligations, the effect of a filing upon the Company's common stock or its shareholders, continued trading of the Company's stock on the TSX, or the effect of any termination of reporting obligations on the Company's assets, liabilities and results. Westaim disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise. Accordingly, readers are advised not to place undue reliance on forward-looking statements, and should not rely on this information at any date other than the date of this news release. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.


'/>"/>
SOURCE Westaim Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Westaim announces sale of iFire Technology Ltd. assets
2. Westaim announces 2008 second quarter results
3. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Second Quarter Results
4. Westaim announces 2008 first quarter results
5. Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders
6. Westaim announces 2007 year-end results
7. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
8. Westaim reduces ABCP exposure
9. Westaim announces 2007 third quarter results
10. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results
11. The Westaim Corporation update on status of short-term investments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... While it’s often important to take certain medications during the night, finding them ... a solution. , She developed a prototype for MOTION LIGHT-UP PILL BOX to provide ... need to turn on a light when taking medication during the night, allowing the ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate ... primary prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. ...
(Date:10/13/2017)... ... 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud ... and unique items from across the nation, this holiday-themed event will raise funds and ... the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob ... sciatica in a new episode of "Success Files," which is an award-winning educational ... and investigates each subject in-depth with passion and integrity. , Sciatica occurs when ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... 2017  As the latest Obamacare repeal effort moves ... (R-LA) and Lindsey Graham (R-SC) medical ... device industry is in an odd place.  The industry ... excise tax on medical device sales passed along with ... patients, increased visits and hospital customers with the funding ...
(Date:9/19/2017)... medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound energy ... ... Jim Bertolina, PhD ... Tom Tefft ... executive Josh Stopek , PhD, who has led R&D and business development teams at ...
(Date:9/18/2017)... KALAMAZOO, Mich. , Sept. 18, 2017 ... , and OptiMed Specialty Pharmacy of Kalamazoo, ... offer a strategic hub service that expedites and streamlines ... personal spirometer, Spiro PD 2.0, and wellness management services.  ... is a medical device used to measure lung function ...
Breaking Medicine Technology: